NRG-BR003 A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

IRB16-000
Cancer, Cancer - Breast
Grace Makari-Judson, MD

Damour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

The purpose of this study is to compare the effects of carboplatin given with the usual chemotherapy drugs after surgery, compared to the usual chemotherapy drugs given without carboplatin.
Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Rae Lynn Defeo
413-794-0255